Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France · Delayed Price · Currency is EUR 0.3270
+0.0070 (2.19%)
Last updated: Oct 22, 2026, 5:29 PM CEST
EPA:ALOPM Revenue
In the year 2025, Oncodesign Precision Medicine Société anonyme had annual revenue of 1.81M EUR with 10.87% growth. Oncodesign Precision Medicine Société anonyme had revenue of 1.07M in the half year ending December 31, 2025, with 57.63% growth. That makes Oncodesign Precision Medicine Société anonyme the 42,329th largest company in the world by revenue and 563rd in France.
Revenue
1.81M
Revenue Growth
+10.87%
P/S Ratio
3.42
Revenue / Employee
n/a
Employees
13
Market Cap
6.23M
Revenue by Segment
- Products Annexed Activities 155.63K 59.6%
- Taxable Services 105.52K 40.4%
Fiscal year ended Dec 31, 2025 See the full EPA:ALOPM breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.81M | 177.80K | 10.87% |
| Dec 31, 2024 | 1.64M | -104.72K | -6.02% |
| Dec 31, 2023 | 1.74M | -6.55M | -79.02% |
| Dec 31, 2022 | 8.29M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.